InvestorsHub Logo

rosemountbomber

09/29/20 12:20 PM

#302013 RE: Bill B #302012

Have to agree with you on this Bill. No way to compete with these large Generic companies for a small one product company.

raistthemage

09/29/20 12:22 PM

#302014 RE: Bill B #302012

They have a supplier advantage and could do a deal with say Teva for an AG now and probably keep most of the US market money forever with Teva getting a big cut and the other generics staying away... But the supplier advantage will not last forever.

But JT is of course too stupid to do this that is if he is not waiting to take the company private to do the smart thing.